Diabetes not only affects patients' physical health but also imposes a significant social burden. According to the International Diabetes Federation, more than 460 million people worldwide are currently living with diabetes, and this number is expected to continue rising in the coming decades. Therefore, increasing awareness of diabetes prevention and treatment, as well as ensuring equitable access to diabetes care resources, is a pressing challenge for global healthcare.
As a leading biotechnology company in China, Hotgen remains committed to providing high-quality, reliable diabetes testing products to support global efforts in diabetes prevention and control.
Discover the precision and reliability of Hotgen IVD products. Contact us today to enrich your product portfolio & enhance your diagnostic capabilities and patient care.
Tel
Add
No. 55 Qingfeng West Road, Daxing District, 102629, Beijing, China